Researchers bend DNA strands with light, revealing a new way to study the genome
On Sep. 9, 2024, a Princeton University team announced they had developed a way to probe chromosomes and…
CSL’s Novel Gene Therapy HEMGENIX® (etranacogene dezaparvovec-drlb) Demonstrated Durable Protection and Sustained Factor IX Activity Levels for People Living with Hemophilia B
On Dec. 10, 2022, CSL announced data affirming the long-term durability and safety of single-infusion HEMGENIX® (etranacogene dezaparvovec-drlb)…
Innovation Pharmaceuticals reported Brilacidin inhibited Omicron, Delta, Gamma and Alpha SARS-CoV-2 variants
On Jun. 23, 2022, Innovation Pharmaceuticals reported that Brilacidin, the Company’s defensin-mimetic drug candidate exhibiting broad-spectrum antiviral activity,…
USDA confirmed highly pathogenic Avian influenza in New Jersey
On May 18, 2022, the U.S. Department of Agricultureï¾’s Animal and Plant Health Inspection Service confirmed the presence…
USDA issued a conditional license for mink Coronavirus
On Apr. 27, 2022, the U.S. Department of Agricultureï¾’s Animal and Plant Health Inspection Service announced it had…
The US Department of Defense identified more troops to help administer COVID-19 vaccine
On Mar. 10, 2021, the U.S. Department of Defense (DOD) announced that it had identified additional personnel authorized…
COVID-19 reduced US life expectancy, especially among Black and Latino populations
On Jan. 14, 2021, USC and Princeton researchers reported that the COVID-19 pandemic, which claimed more than 336,000…
Cue’s Molecular, point-of-care COVID-19 tests deployed to five states in HHS and DOD pilot program
On Nov. 19, 2020, Cue Health announced that, as of November 9, the U.S. Department of Health and…
Seqirus began shipping 2020/21 influenza vaccines to U.S. market
On Jul. 30, 2020, Seqirus announced it had begun shipping its portfolio of seasonal influenza vaccines to customers…
ViralClear opened enrollment with first patient dosing in phase II human trial of anti-viral MMPD oral solution for treatment of COVID-19
On Jun. 17, 2020, BioSig Technologies, and its subsidiary, ViralClear, announced that it had commenced patient enrollment with…
The FDA issued EUA for first diagnostic test using at-home collection of saliva specimens
On May 8, 2020, the FDA issued an emergency use authorization (EUA) to Rutgers Clinical Genomics Laboratory for…
New virus detection process under development at Rutgers-Camden
On Apr. 21, 2020,the fight against the coronavirus is underway in a Rutgers Universityï¾–Camden research laboratory, where chemistry…
More than 800 employees from Rutgers, Robert Wood Johnson University Hospital and University Hospital participate in a pioneering study
On Apr. 21, 2020, Rutgers University announced it has launched the nation’s largest prospective study of health care…
Pluristem treated first COVID-19 patient in US under FDA single patient expanded access program
On Apr. 13, 2020, Pluristem Therapeutics announced it has treated its first patient suffering from COVID-19 complications in…
Merck donated 300,000 masks to New Jersey for COVID-19 emergency response
On Mar. 25, 2020, Merck announced it had donated 300,000 masks to New Jersey’s Office of Homeland Security…
New COVID-19 assay adapted to run on T2 Biosystems’ FDA-cleared T2Dx Instrument
On Mar. 24, 2020, T2 Biosystems announced it had entered into a worldwide licensing agreement for a rapid…
T2 Biosystems announced worldwide licensing agreement of COVID-19, novel Coronavirus assay
On Mar. 24, 2020, T2 Biosystems announced it has entered into a worldwide licensing agreement for a rapid…
Acura Pharmaceuticals provides an update on the development of LTX-03
On Mar. 23, 2020, Acura Pharmaceuticals announced that Abuse Deterrent Pharma, its licensee of LTX-03 (Hydrocodone Bitartrate and…
Research revealed new coronavirus stable for hours on surfaces
On Mar. 17, 2020, the virus that causes coronavirus disease 2019 (COVID-19) was stable for several hours to…
BioReference Laboratories and State of New Jersey provided testing for Coronavirus 2019
On Mar. 20, 2020, BioReference Labs, an OPKO Health company, announced a collaboration with the State of New…
FDA approved Fluad Quadrivalent (influenza vaccine, adjuvanted; Seqirus) for adults 65 years and older
On Feb. 24, 2020, Seqirus announced that the U.S. Food and Drug Administration (FDA) had approved the first…
Biotechnology | COVID-19 | Infectious Disease | Life Science News | Therapeutics | Vaccine | Women's Health
Sorrento and Celularity to initiate emergency allogeneic natural killer cell therapy development for Coronavirus infection
On Jan. 29, 2020, Sorrento Therapeutics announced it had initiated a clinical and manufacturing collaboration with Celularity, a…
Seqirus’ Received Health Canada approval of first cell-based seasonal influenza vaccine
On Dec. 11, 2019, Seqirus announced that its cell-based quadrivalent influenza vaccine (QIVc) had received approval from Health…
Seqirus’ Next Generation Cell-based Influenza Vaccine Shows Significantly Greater Effectiveness Compared to Standard Egg-based Options in the 2017-18 US Influenza Season
On Dec. 5, 2018, Seqirus, a CSL subsidiary, announced real-world data showing that its cell-based quadrivalent influenza vaccine…
Teva Pharmaceuticals announced North America headquarters moved to New Jersey
On Jul. 6, 2018, Teva Pharmaceuticals announced it would move its U.S. headquarters to Parsippany-Troy Hills, New Jersey…
The Lombardi Comprehensive Cancer Center became the 16th National Cancer Institute-designated Comprehensive Cancer Center
In 2018, the Lombardi Comprehensive Cancer Center became the 16th National Cancer Institute-designated Comprehensive Cancer Center funded with…
Bristol-Myers Squibb announced closure of Seattle’s ZymoGenetics operation
On Dec. 13, 2016, Bristol-Myers Squibb announced that it would not renew its lease at the Lake Union…
Biotechnology | Diagnostics | Disease | Genomics | Life Science News | Non-Profit Research | Oncology | Therapeutics
The Omar Boraie Chair in Genomic Science was established at Rutgers Cancer Institute
On Oct. 21, 2015, the Omar Boraie Chair in Genomic Science was established at Rutgers Cancer Institute. The…
Stephen J Elledge and Evelyn M Witkin received Lasker Award
On Sept. 18, 2015, Stephen J. Elledge from Brigham and Women’s Hospital and Evelyn M. Witkin from Rutgers…
Rutgers Cancer Institute of New Jersey was one of seven worldwide sites to offer debulking prostatectomy
On May 5, 2015, Rutgers Cancer Institute of New Jersey was one of seven international sites to offer…